Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells.
about
p53-reactive T cells are associated with clinical benefit in patients with platinum-resistant epithelial ovarian cancer after treatment with a p53 vaccine and gemcitabine chemotherapy.How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive.Resveratrol ameliorates Lewis lung carcinoma-bearing mice development, decreases granulocytic myeloid-derived suppressor cell accumulation and impairs its suppressive ability
P2860
Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells.
@en
Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells.
@nl
type
label
Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells.
@en
Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells.
@nl
prefLabel
Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells.
@en
Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells.
@nl
P2093
P2860
P1433
P1476
Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells.
@en
P2093
Brian Till
Quanli Gao
Zibing Wang
P2860
P304
P356
10.1080/2162402X.2017.1331807
P577
2017-06-16T00:00:00Z